PCN46 Cost-Efficacy Analysis of Licensed Drugs for the Treatment of Metastatic Castrate Resistant Prostate Cancer Post Docetaxel Based on Hospital Drug Evaluation Methodology in Spain

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1239
https://www.valueinhealthjournal.com/article/S1098-3015(12)02952-X/fulltext
Title : PCN46 Cost-Efficacy Analysis of Licensed Drugs for the Treatment of Metastatic Castrate Resistant Prostate Cancer Post Docetaxel Based on Hospital Drug Evaluation Methodology in Spain
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02952-X&doi=10.1016/j.jval.2012.08.1239
First page : A417
Section Title : Cancer
Open access? : No
Section Order : 743
Categories :
Tags :
Regions :
ViH Article Tags :